abstract |
The present invention relates to guanidine compounds and their use for inhibiting mitochondrial oxidative phosphorylation (OXPHOS). More particularly, the present invention relates to a pharmaceutical composition for preventing or treating diseases related to OXPHOS, particularly cancer, by suppressing mitochondrial oxidative phosphorylation and reprogramming cell metabolism. |